Bavencio

A drug that binds to the protein PD-L1 to help immune cells kill cancer cells better and is used to treat different types of cancer. Bavencio is used alone or with other drugs to treat certain types of advanced renal cell carcinoma (a type of kidney cancer), urothelial carcinoma (a type of bladder cancer), and Merkel cell carcinoma (a rare type of skin cancer). It is also being studied in the treatment of other types of cancer. Bavencio may block PD-L1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called avelumab.